AKIN GUMP STRAUSS HAUER & FELD

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Trade association.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $120,000.00 income · posted Jul 20, 2026

Bills named in this filing 2

Lobbying activity 3

Health Issues

Issues related to budget reconciliation; Issues related to Most Favored Nation pricing proposals; Issues related drug pricing.

Trade (domestic/foreign)

Issues related to IP protection; Issues related to market access; Issues related to PhRMA Section 232 tariffs.

Issues related to patent reform legislation; Issues related to H.R. 3160/S. 1553 - PREVAIL Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.